$PHVS
Pharvaris N.V. Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
$31.40
▲+2.98%+$0.910
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePharvaris N.V. Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is PHVS up today? It is at $31.40 (+2.98%), and our scanner flagged it 138 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PHVS spikes, and full due diligence on PHVS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PHVS 138 times in the last 30 days. Create a free account to track $PHVS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PHVS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on PHVS today, peaking at 11.3x its normal volume. A recent catalyst in the news: “Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy.” Early read: bullish.
Likely catalystForeign issuer report (6-K), from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 25, 2026 · 11 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
4,455,863 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $29.68/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Monges Viviane Director | Sold (automatic/other) | -12K 0.02% of company | sold 69% | 6K | $396K at $33.05 | Sep 23, 26 |
Monges Viviane Director | Other | 12K 0.02% of company | added 100% | 17K | $96K at $8.05 | Sep 23, 26 |
Schikan Johannes Gerardus Christiaan Petrus Director | Sold (automatic/other) | -800 | sold 0.7% | 115K | $29K at $36.19 | Sep 22, 26 |
Schikan Johannes Gerardus Christiaan Petrus Director | Other | 800 | added 0.7% | 116K | $16K at $20.00 | Sep 22, 26 |
Lu Peng Officer | Other | 45K 0.07% of company | added 70% | 110K | $117K at $2.59 | Sep 22, 26 |
Nassif David W. Officer | Sold (automatic/other) | -6K | sold 5.0% | 114K | $219K at $36.47 | Sep 21, 26 |
Nassif David W. Officer | Sold (automatic/other) | -500 | sold 0.4% | 114K | n/a | Sep 21, 26 |
Modig Berndt Officer | Other | 300K 0.5% of company | added 30% | 1.30M | $10.5M at $35.00 | Sep 17, 26 |
Lesage Anne Officer | Sold (automatic/other) | -20K 0.03% of company | sold 21% | 74K | $765K at $38.27 | Sep 17, 26 |
Glassman Robert Director | Sold (automatic/other) | -14K 0.02% of company | sold 58% | 11K | $559K at $38.56 | Sep 17, 26 |
Glassman Robert Director | Other | 14K 0.02% of company | added 100% | 25K | $263K at $18.14 | Sep 17, 26 |
Bjork Elisabeth Director | Sold (automatic/other) | -53K 0.08% of company | sold 78% | 15K | $2.0M at $37.89 | Sep 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
PHVS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on PHVS today, peaking at 11.3x its normal volume. A recent catalyst in the news: “Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy.” Early read: bullish.
PHVS last traded at $31.40, up 2.98% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Pharvaris N.V. Ordinary Shares (PHVS) is next expected to report earnings on Wednesday, November 11, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PHVS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PHVS 138 times in the last 30 days.
PHVS (Pharvaris N.V. Ordinary Shares) trades on XNAS, with a market cap of about $1.99B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PHVS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PHVS discussion
Sign in to ask a question or join the discussion.